Bio-Rad Laboratories ddPCR Microsatellite Instability (MSI) Assay

Friday, 19 July, 2019 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad’s ddPCR Microsatellite Instability (MSI) Assay can be completed in one day on a ddPCR-based platform to quantify the level of MSI present in colorectal tumours.

Using either a blood or FFPE sample, the RUO assay quantitatively identifies mutations in five loci that lead to identification of MSI status. Colorectal tumours that test positive for MSI-high are candidates for treatment with immune-checkpoint inhibitors.

Simple and sensitive, the assay provides a standardised output that does not require a pathologist’s interpretation. The test can use patient blood samples in the absence of tumour tissue and does not require matched normal tissue or normal blood samples.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

Meridian Bioscience Specimen-specific, inhibitor-tolerant master mixes

Scientists can skip DNA/RNA extraction with Meridian's inhibitor-tolerant, specimen-specific...

Molecular Devices microplate readers

A microplate reader is an essential instrument for a vast range of applications, from basic...

Dojindo Cytotoxicity LDH Assay Kit-WST

Dojindo's Cytotoxicity LDH Assay Kit-WST can be applied with or without supernatant transfer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd